Nanoliposomal irinotecan in metastatic pancreatic cancer

Lancet. 2016 May 14;387(10032):1997. doi: 10.1016/S0140-6736(16)30463-9.

Authors

Ioan Milosevic¹, Henry Drysdale², Ben Goldacre²; COMPare project team

Affiliations

¹ Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Services, Oxford, OX2 6GG, UK. Electronic address: [email protected].
² Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Services, Oxford, OX2 6GG, UK.

PMID: 27203772
DOI: 10.1016/S0140-6736(16)30463-9

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Pancreatic Ductal / drug therapy*
Female
Humans
Male
Pancreatic Neoplasms / drug therapy*